Jin-fu F. Xu

Multi-omics profiling of fungal balls in chronic pulmonary aspergillosis patients reveals microbiome dynamics and metabolic adaptations.

Journal: mBio

Published: May 05, 2026

Microbiome and its role in bronchiectasis.

Journal: Therapeutic advances in respiratory disease

Published: April 29, 2026

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

Journal: American journal of respiratory and critical care medicine

Published: April 01, 2026

Annual progress in the clinical management and research of bronchiectasis 2025

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: March 12, 2026

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Journal: BMJ open respiratory research

Published: February 23, 2026

An immune-poised state of human bronchial epithelial cells mediates defense against RSV in adults.

Journal: Nature communications

Published: February 14, 2026

An immune-poised state of human bronchial epithelial cells mediates RSV resistance in adults.

Journal: bioRxiv : the preprint server for biology

Published: February 12, 2026

Key updates in the 2025 ERS/ATS guideline for the diagnosis of primary ciliary dyskinesia

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: February 02, 2026

Precise etiological diagnosis of bronchiectasis: value and challenges from routine screening to precision intervention

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: February 02, 2026

Highlights and interpretation of the 2025 European Respiratory Society clinical practice guideline for the management of adult bronchiectasis

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: February 02, 2026

Multi-omics profiling of fungal balls in chronic pulmonary aspergillosis patients reveals microbiome dynamics and metabolic adaptations.

Multi-omics profiling of fungal balls in chronic pulmonary aspergillosis patients reveals microbiome dynamics and metabolic adaptations.

Microbiome and its role in bronchiectasis.

Microbiome and its role in bronchiectasis.

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

Annual progress in the clinical management and research of bronchiectasis 2025

Annual progress in the clinical management and research of bronchiectasis 2025

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

An immune-poised state of human bronchial epithelial cells mediates defense against RSV in adults.

An immune-poised state of human bronchial epithelial cells mediates defense against RSV in adults.

An immune-poised state of human bronchial epithelial cells mediates RSV resistance in adults.

An immune-poised state of human bronchial epithelial cells mediates RSV resistance in adults.

Key updates in the 2025 ERS/ATS guideline for the diagnosis of primary ciliary dyskinesia

Key updates in the 2025 ERS/ATS guideline for the diagnosis of primary ciliary dyskinesia

Precise etiological diagnosis of bronchiectasis: value and challenges from routine screening to precision intervention

Precise etiological diagnosis of bronchiectasis: value and challenges from routine screening to precision intervention

Highlights and interpretation of the 2025 European Respiratory Society clinical practice guideline for the management of adult bronchiectasis

Highlights and interpretation of the 2025 European Respiratory Society clinical practice guideline for the management of adult bronchiectasis

Pseudomonas aeruginosa adaptation and persistence in the aspergilloma microbiome revealed by integrated multi-omics.

Pseudomonas aeruginosa adaptation and persistence in the aspergilloma microbiome revealed by integrated multi-omics.

Taking a wider view: The Lancet Respiratory Medicine Commission on bronchiectasis.

Taking a wider view: The Lancet Respiratory Medicine Commission on bronchiectasis.